Lotte Biologics announced on the 1st that it has signed a business agreement with Millipore Sigma, Merck's North American life science division to strengthen its bio business capabilities.

With this agreement, the two companies will cooperate in promoting new biopharmaceutical businesses such as next-generation treatments and expanding Syracuse factories in the U.S. Millipore Sigma is a life science division in North America operated by Merck, a global science and technology company based in Germany. Lotte Biologics will receive overall technical support related to its bio business, including manufacturing solutions and human resource training, from Millipore Sigma.

Lotte Biologics expect